SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001626199-23-000061
Filing Date
2023-04-27
Accepted
2023-04-27 15:58:14
Documents
3
Period of Report
2023-04-21

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_168262547750681.html 3  
1 FORM 3 wf-form3_168262547750681.xml 3 11557
2 POAHTML poaremy.htm EX-24 578
3 POAJPG poaremy001.jpg GRAPHIC 156794
  Complete submission text file 0001626199-23-000061.txt   229779
Mailing Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102
Business Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102 206-788-4545
ALPINE IMMUNE SCIENCES, INC. (Issuer) CIK: 0001626199 (see all company filings)

IRS No.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ALPINE IMMUNE SCIENCES, INC. 185 EAST BLAINE STREET, SUITE 200 SEATTLE WA 98012
Business Address
DURAND REMY (Reporting) CIK: 0001973027 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37449 | Film No.: 23856525